P

Personalis
D

PSNL

6.23500
USD
-0.21
(-3.18%)
مغلق
حجم التداول
79,354
الربح لكل سهم
-1
العائد الربحي
-
P/E
-5
حجم السوق
550,707,235
أصول ذات صلة
B
BEAM
0.030
(0.18%)
16.650 USD
C
CRSP
1.580
(3.80%)
43.190 USD
E
EDIT
-0.02000
(-0.93%)
2.13500 USD
F
FATE
-0.03500
(-2.85%)
1.19500 USD
I
IOVA
-0.06000
(-2.89%)
2.01500 USD
K
KURA
-0.30000
(-4.62%)
6.19500 USD
N
NTLA
0.61500
(6.86%)
9.58500 USD
S
SGMO
-0.01250
(-2.52%)
0.48260 USD
V
VCEL
-0.098
(-0.24%)
41.480 USD
المزيد
الأخبار المقالات

العنوان: Personalis

القطاع: Healthcare
الصناعة: Diagnostics & Research
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.